EcoDrugPlus

Ensembl ID : ENSDLAG00005027584
Gene Symbol: -
Cross references: -
259 Possible Orthologues:

Ensembl ID : ENSDLAG00005027837
Gene Symbol: -
Cross references: -
160 Possible Orthologues:

Ensembl ID : ENSDLAG00005027874
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSDLAG00005028030
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSDLAG00005028066
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSDLAG00005028939
Gene Symbol: -
Cross references: -
340 Possible Orthologues:

Ensembl ID : ENSDLAG00005029050
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSDLAG00005029052
Gene Symbol: -
1 Cross references
492 Possible Orthologues:

Ensembl ID : ENSDLAG00005029287
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSDLAG00005029390
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSDLAG00005029413
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSDLAG00005029064
Gene Symbol: -
Cross references: -
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).